Anterior cingulate cortical transplantation in transgenic Huntington's disease mice

被引:41
|
作者
van Dellen, A
Deacon, R
York, D
Blakemore, C
Hannan, AJ
机构
[1] Univ Oxford, Physiol Lab, Oxford OX1 3PT, England
[2] Univ Oxford, Dept Expt Psychol, Oxford OX1 3PT, England
[3] Univ KwaZulu Natal, Sch Med, ZA-4001 Durban, Kwazulu Natal, South Africa
关键词
Huntington's; polyglutamine; transplantation; anterior cingulate; corticostriatal;
D O I
10.1016/S0361-9230(01)00655-4
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Huntington's disease (HD) is an autosomal dominant disorder involving progressive neurodegeneration of the corpus striatum and cerebral cortex. Transgenic mice, in which exon 1 of the human HD gene with an expanded trinucleotide repeat is expressed, develop a neurodegenerative syndrome that closely models human HD. Transplantation of wild-type donor cortex into the anterior cingulate cortex of neonatal HD mice (R6/1 line) was found to delay the onset of a specific motor deficit, rear-paw clasping. However, transplantation did not significantly enhance motor performance on a suspended horizontal rod, a behavioural measure of fine motor co-ordination. Control experiments in which the anterior cingulate cortex was resected, but no donor cortical tissue was transplanted, showed no behavioural benefit. In fact, wild-type littermate mice that also underwent this surgical resection, were found to develop motor deficits similar to those exhibited by non-resected HD mice. These results suggest that the anterior cingulate cortex is an important area of pathology in this HD model, and that therapeutic approaches to HD may need to target cortical, as well as striatal areas. (C) 2001 Elsevier Science Inc.
引用
收藏
页码:313 / 318
页数:6
相关论文
共 50 条
  • [1] Impaired learning-dependent cortical plasticity in Huntington's disease transgenic mice
    Cybulska-Klosowicz, A
    Mazarakis, NK
    Van Dellen, A
    Blakemore, C
    Anthony, AJ
    Kossut, M
    NEUROBIOLOGY OF DISEASE, 2004, 17 (03) : 427 - 434
  • [2] Altered endocytosis in Huntington's disease transgenic mice
    Zabel, C.
    Kaindl, A.
    Wacker, M.
    Bates, G.
    Klose, J.
    MOLECULAR & CELLULAR PROTEOMICS, 2005, 4 (08) : S196 - S196
  • [3] Magnetic biomineralisation in Huntington's disease transgenic mice
    Beyhum, W
    Hautot, D
    Dobson, J
    Pankhurst, QA
    FIFTH INTERNATIONAL CONFERENCE ON FINE PARTICLE MAGNETISM, 2005, 17 : 50 - 53
  • [4] Striatal transplantation in a transgenic mouse model of Huntington's disease
    Dunnett, SB
    Carter, RJ
    Watts, C
    Torres, EM
    Mahal, A
    Mangiarini, L
    Bates, G
    Morton, AJ
    EXPERIMENTAL NEUROLOGY, 1998, 154 (01) : 31 - 40
  • [5] Evaluation of treatment stategies for Huntington's disease in transgenic mice
    Schiefer, J
    Lüesse, HG
    Sprünken, A
    Puls, C
    Milkereit, A
    Milkereit, E
    Kosinski, CM
    ACTA NEUROPATHOLOGICA, 2002, 104 (05) : 568 - 568
  • [6] A comprehensive glycome profiling of Huntington's disease transgenic mice
    Gizaw, Solomon T.
    Koda, Toshiaki
    Amano, Maho
    Kamimura, Keiko
    Ohashi, Tetsu
    Hinou, Hiroshi
    Nishimura, Shin-Ichiro
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2015, 1850 (09): : 1704 - 1718
  • [7] Striking changes in anxiety in Huntington's disease transgenic mice
    File, SE
    Mahal, A
    Mangiarini, L
    Bates, GP
    BRAIN RESEARCH, 1998, 805 (1-2) : 234 - 240
  • [8] Dopamine restores cortical function Huntington's disease mice
    Cummings, DM
    Milner, AJ
    Dallérac, GM
    Vatsavayai, SC
    Hirst, MC
    Murphy, KPSJ
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2005, 76
  • [9] The use of transgenic and knock-in mice to study Huntington's disease
    Hickey, MA
    Chesselet, MF
    CYTOGENETIC AND GENOME RESEARCH, 2003, 100 (1-4) : 276 - 286
  • [10] Huntington's disease transgenic mice are resistant to global cerebral ischemia
    Schiefer, J
    Alberty, A
    Dose, T
    Oliva, S
    Noth, J
    Kosinski, CM
    NEUROSCIENCE LETTERS, 2002, 334 (02) : 99 - 102